A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.
Lisa CubaPauline DürrKatja GessnerBabette HäckerRainer FietkauJürgen SieblerMarianne PavelMarkus F NeurathCarola BerkingBernd WullichValeska BrücklMatthias W BeckmannMartin F FrommFrank DörjePublished in: JCO oncology practice (2024)
Despite not reaching the primary implementation outcome, the AMBORA Center included more treatment units and demonstrated patient benefit of the AMBORA care program by meeting all effectiveness outcomes. We outlined quantitative and qualitative implementation characteristics to enhance outreach and foster further dissemination of centers to optimize medication safety with OAT.
Keyphrases
- quality improvement
- healthcare
- type iii
- primary care
- systematic review
- randomized controlled trial
- palliative care
- clinical trial
- study protocol
- adverse drug
- case report
- high resolution
- emergency department
- type diabetes
- phase iii
- pain management
- combination therapy
- skeletal muscle
- cell therapy
- health insurance
- metabolic syndrome
- weight loss
- affordable care act